Adagrasib shows CNS penetration and encouraging intracranial activity for KRASG12C-mutated NSCLC and active, untreated CNS metastases

Spotlight on global cancer control at ASCO 2022

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

Comment: Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021

First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and brain metastases: Results From CheckMate 9LA

OncoAlert and ecancer weekly round up for August 23rd - August 29th, 2021

OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021

Marizomib in combination with temozolomide-based radiochemotherapy for newly diagnosed glioblastoma

Rare inherited pathogenic germline variants observed in sporadic paediatric neuroblastoma cases